Mumbai, India

Anil Pareek

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Ipca Laboratories Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anil Pareek. Retrieved from https://idiyas.com/inventor/anil-pareek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anil Pareek: Innovator in Diabetes Treatment

Introduction

Anil Pareek is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes mellitus. His innovative approach combines established compounds with new therapeutic strategies.

Latest Patents

Anil Pareek holds a patent for a pharmaceutical composition aimed at treating diabetes mellitus. The patent, titled "Pharmaceutical compositions for the treatment of diabetes mellitus," discloses a formulation that includes Hydroxychloroquine or its pharmaceutically acceptable salt along with at least one antidiabetic compound. This combination is designed to enhance the efficacy of diabetes treatment.

Career Highlights

Anil Pareek is associated with Ipca Laboratories Limited, a prominent pharmaceutical company in India. His work at Ipca Laboratories has allowed him to focus on developing innovative solutions for chronic health conditions, particularly diabetes.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Anil Pareek's contributions to diabetes treatment through his patent and work at Ipca Laboratories highlight his role as an important figure in pharmaceutical innovation. His efforts continue to pave the way for advancements in healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…